Literature DB >> 18398918

Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium.

Pallavi B Limaye1, William C Bowen, Anne V Orr, Jianhua Luo, George C Tseng, George K Michalopoulos.   

Abstract

UNLABELLED: Previous studies from our laboratory have demonstrated that hepatocytes can transdifferentiate into biliary epithelium (BE) both in vivo and in vitro; however, the mechanisms are unclear. The current study was designed to investigate the mechanisms of hepatocyte transdifferentiation in vitro. Rat hepatocytes were cultured in roller bottles to obtain hepatocyte organoid cultures, which were stimulated with various growth factors (GFs) including hepatocyte growth factor (HGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), stem cell factor (SCF), macrophage-stimulating protein (MSP), fibroblast growth factor-a (FGF-a), fibroblast growth factor-b (FGF-b), and fibroblast growth factor-8b (FGF-8b). Only the cultures treated with HGF, EGF, and their combination exhibited formation of hepatocyte-derived biliary epithelium (BE) despite the presence and activation of all the pertinent cognate membrane receptors of the rest of the GFs. Microarray analysis of the organoid cultures identified specific up-regulation of approximately 500 target genes induced by HGF and EGF, including members of the extracellular matrix (ECM) protein family, Wnt/beta-catenin pathway, transforming growth factor beta (TGF-beta)/bone morphogenetic protein (BMP) pathway, and CXC (cysteine-any amino acid-cysteine) chemokines. To investigate the downstream signaling involved in hepatocyte to biliary epithelial cell (BEC) transdifferentiation, we investigated expression and activities of mitogen-activated protein (MAP) kinases [extracellular signal-regulated kinase (ERK)1/2, p38, and c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK)] as well as serine/threonine kinase AKT. The analysis indicated that AKT phosphorylation was particularly increased in cultures treated with HGF, EGF, and their combination. Whereas phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 completely inhibited biliary epithelium formation, AKT inhibitor could only moderately reduce formation of BE in the organoid cultures treated with HGF+EGF. Most of the HGF+EGF target genes were altered by LY294002.
CONCLUSION: Taken together, these data indicate that hepatocyte to BE transdifferentiation is regulated by HGF and EGF receptors and that PI3 kinase-mediated signaling independent of AKT is a crucial component of the transdifferentiation process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398918      PMCID: PMC2615562          DOI: 10.1002/hep.22221

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

Review 1.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

2.  Integrin-linked kinase is involved in matrix-induced hepatocyte differentiation.

Authors:  Vasiliki Gkretsi; William C Bowen; Yu Yang; Chuanyue Wu; George K Michalopoulos
Journal:  Biochem Biophys Res Commun       Date:  2006-12-20       Impact factor: 3.575

3.  The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells.

Authors:  Masayuki Adachi; Yosuke Osawa; Hiroshi Uchinami; Tadahiro Kitamura; Domenico Accili; David A Brenner
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

4.  Involvement of phosphatidylinositol 3-kinase and extracellular-regulated kinase in hepatic stellate cell antioxidant response and myofibroblastic transdifferentiation.

Authors:  John F Reichard; Dennis R Petersen
Journal:  Arch Biochem Biophys       Date:  2006-01-11       Impact factor: 4.013

5.  A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix.

Authors:  Yuan-Ping Han; Chunli Yan; Ling Zhou; Lan Qin; Hidekazu Tsukamoto
Journal:  J Biol Chem       Date:  2007-02-23       Impact factor: 5.157

6.  beta-Catenin is critical for early postnatal liver growth.

Authors:  Udayan Apte; Gang Zeng; Michael D Thompson; Peggy Muller; Amanda Micsenyi; Benjamin Cieply; Klaus H Kaestner; Satdarshan P S Monga
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-01       Impact factor: 4.052

7.  Involvement of signaling of VEGF and TGF-beta in differentiation of sinusoidal endothelial cells during culture of fetal rat liver cells.

Authors:  Masayuki Yoshida; Yuji Nishikawa; Yasufumi Omori; Toshiaki Yoshioka; Takuo Tokairin; Peter McCourt; Katsuhiko Enomoto
Journal:  Cell Tissue Res       Date:  2007-04-21       Impact factor: 5.249

8.  Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis.

Authors:  Marjorie Pick; Lisa Azzola; Anna Mossman; Edouard G Stanley; Andrew G Elefanty
Journal:  Stem Cells       Date:  2007-06-07       Impact factor: 6.277

9.  Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation.

Authors:  N Kojima; M Hori; T Murata; Y Morizane; H Ozaki
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

10.  Ductular proliferation in liver tissues with severe chronic hepatitis B: an immunohistochemical study.

Authors:  Yao-Kai Chen; Xu-Xia Zhao; Jun-Gang Li; Song Lang; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

View more
  42 in total

1.  Phenotypic fidelity (or not?) of epithelial cells in the liver.

Authors:  George K Michalopoulos
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

2.  Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Authors:  Shirish Paranjpe; William C Bowen; Wendy M Mars; Anne Orr; Meagan M Haynes; Marie C DeFrances; Silvia Liu; George C Tseng; Anastasia Tsagianni; George K Michalopoulos
Journal:  Hepatology       Date:  2016-10-01       Impact factor: 17.425

Review 3.  Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.

Authors:  George K Michalopoulos; Zahida Khan
Journal:  Gastroenterology       Date:  2015-08-14       Impact factor: 22.682

Review 4.  Cellular homeostasis and repair in the mammalian liver.

Authors:  Ben Z Stanger
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 5.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

6.  If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.

Authors:  Kari Nejak-Bowen
Journal:  Gene Expr       Date:  2019-08-22

Review 7.  Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Authors:  Keisaku Sato; Marco Marzioni; Fanyin Meng; Heather Francis; Shannon Glaser; Gianfranco Alpini
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

8.  Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.

Authors:  Alphonse E Sirica; Michael H Nathanson; Gregory J Gores; Nicholas F Larusso
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

9.  Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.

Authors:  Jun Sang Bae; Ha Na Choi; Sang Jae Noh; Byung Hyun Park; Kyu Yun Jang; Cheol Keun Park; Woo Sung Moon
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

Review 10.  Liver regeneration: alternative epithelial pathways.

Authors:  George K Michalopoulos
Journal:  Int J Biochem Cell Biol       Date:  2009-09-27       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.